Edition:
United Kingdom

Fortress Biotech Inc (FBIO.OQ)

FBIO.OQ on NASDAQ Stock Exchange Capital Market

3.46USD
22 May 2018
Change (% chg)

$-0.06 (-1.70%)
Prev Close
$3.52
Open
$3.50
Day's High
$3.50
Day's Low
$3.45
Volume
2,520
Avg. Vol
39,992
52-wk High
$5.53
52-wk Low
$3.17

Chart for

About

Fortress Biotech, Inc., formerly Coronado Biosciences, Inc., is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of autoimmune diseases and cancer. Its sole product candidate is CNDO-109. The Company is also focused on acquiring, developing and commercializing... (more)

Overall

Beta: 0.15
Market Cap(Mil.): $172.46
Shares Outstanding(Mil.): 52.90
Dividend: --
Yield (%): --

Financials

  FBIO.OQ Industry Sector
P/E (TTM): -- 28.56 32.59
EPS (TTM): -0.88 -- --
ROI: -81.13 13.05 12.60
ROE: -75.42 14.79 14.49

BRIEF-Mustang Bio Reports Q4 Financial Results

* MUSTANG BIO REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

29 Mar 2018

BRIEF-Mustang Bio's Mb-102 Car T Therapy Achieves Complete Response In Phase 1 Clinical Trial

* MUSTANG BIO'S MB-102 (CD123 CAR) CAR T THERAPY ACHIEVES COMPLETE RESPONSE IN ACUTE MYELOID LEUKEMIA AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PHASE 1 CLINICAL TRIAL

11 Dec 2017

BRIEF-Fortress Biotech forms subsidiary Tamid Bio to develop novel aav gene therapies in Orphan Diseases

* FORTRESS BIOTECH FORMS SUBSIDIARY TAMID BIO TO DEVELOP NOVEL AAV GENE THERAPIES IN ORPHAN DISEASES WITH UNMET MEDICAL NEEDS Source text for Eikon: Further company coverage:

05 Dec 2017

Competitors

Earnings vs. Estimates